ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 864

Association of Coronary Artery Calcification with Brown and White Pericardial Adipose Tissue in SLE

Kelly J. Shields, Medicine, Lupus Center of Excellence / Allegheny Health Network, Pittsburgh, PA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: adipose tissue, computed tomography (CT) and coronary artery disease, Lupus

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Cardiovascular Disease and Pregnancy

Session Type: Abstract Submissions (ACR)

Background/Purpose

Women with systemic lupus erythematosus (SLE) have an increased risk of cardiovascular disease (CVD).  We have shown that clinically CVD-free women with SLE have an increased volume of descending aortic perivascular adipose tissue, which is also associated with aortic calcification independent of overall adiposity.  The relative volumes of brown (BAT) versus white adipose tissue (WAT) may also influence the development of exacerbated CVD.  Typically, increased BAT has been associated with a leaner and healthier phenotype, while increased WAT has been associated with an obese-like state. We hypothesized that greater pericardial adipose tissue (PAT) and WAT volumes will be associated with coronary artery calcification (CAC) in clinically CVD-free women with SLE.

Methods

Women participating in the “Heart Effects on Atherosclerosis and Risk of Thrombosis in SLE” (HEARTS) study were clinically CVD-free and diagnosed with SLE for at least 2 years.  CAC was measured using electron beam computed tomography (EBCT) and quantified by Agaston scoring.  The PAT (epicardial + paracardial adipose tissue) was quantified using commercially available software and attenuation values for overall adipose volume (–190 to –30 HU), WAT (-190 to -75HU), and BAT (-75 to -30 HU).  Logistic regression modeling for any CAC was used to evaluate associations.  Models were adjusted for CVD risk factors (age, waist-to-hip ratio, menopausal status and hypertension) and circulating inflammatory markers (C3, C4 and CRP).

Results

The study included 156 SLE women and 46% (72/156) had any CAC.  SLE women with CAC had higher circulating levels of C3 (p=0.0002), C4 (p=0.001), and CRP (p=0.0001). The WAT to BAT ratio (rSpearman=0.35, p=0.006) was significantly correlated with the extent of CAC. In unadjusted logistic regression models PAT (Odds Ratio/OR[95% CI], p-value: 1.02[1.01-1.03], <0.0001), WAT (1.03[1.01-1.04],<0.0001), and BAT (1.05[1.03-1.08],<0.0001) were significantly associated with any CAC.  The three volumetric adipose measures maintained significance after adjusting for CVD risk factors (PAT (p=0.006), WAT (p=0.02), and BAT (p=0.002)) and circulating inflammatory markers (PAT (p=0.002), WAT (p=0.007), and BAT (p=0.0005). 

Conclusion

Approximately half of the clinically CVD-free SLE women in this study had CAC. Traditional CVD risk factors do not explain the exacerbated CVD risk in the SLE population.  We found that PAT and the relative WAT and BAT volumes were independently associated with any CAC even after adjustment for CVD risk factors and circulating inflammatory markers.  Small visceral adipose depots surrounding the heart and vasculature may provide localized inflammation promoting CVD.


Disclosure:

K. J. Shields,
None;

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-coronary-artery-calcification-with-brown-and-white-pericardial-adipose-tissue-in-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology